Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Practicability, safety, and efficacy of a "German model" for opioid conversion to oral levo-methadone.

Ostgathe C, Voltz R, Van Aaaken A, Klein C, Sabatowski R, Nauck F, Gaertner J.

Support Care Cancer. 2012 Sep;20(9):2105-10. doi: 10.1007/s00520-011-1320-8. Epub 2011 Dec 1.

PMID:
22130587
2.

The role of methadone in opioid rotation-a Polish experience.

Leppert W.

Support Care Cancer. 2009 May;17(5):607-12. doi: 10.1007/s00520-008-0537-7. Epub 2008 Nov 29.

PMID:
19043743
3.

Conversion from parenteral to oral methadone.

González-Barboteo J, Porta-Sales J, Sánchez D, Tuca A, Gómez-Batiste X.

J Pain Palliat Care Pharmacother. 2008;22(3):200-5.

PMID:
19042849
4.

Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit.

Mercadante S.

Pain Med. 2012 Mar;13(3):399-404. doi: 10.1111/j.1526-4637.2012.01334.x. Epub 2012 Feb 23.

5.

Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.

Benítez-Rosario MA, Feria M, Salinas-Martín A, Martínez-Castillo LP, Martín-Ortega JJ.

Cancer. 2004 Dec 15;101(12):2866-73.

6.

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.

Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.

Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18.

PMID:
18353696
7.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
8.

Methadone titration in opioid-resistant cancer pain.

Scholes CF, Gonty N, Trotman IF.

Eur J Cancer Care (Engl). 1999 Mar;8(1):26-9.

PMID:
10362950
9.

How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.

Moksnes K, Dale O, Rosland JH, Paulsen O, Klepstad P, Kaasa S.

Eur J Cancer. 2011 Nov;47(16):2463-70. doi: 10.1016/j.ejca.2011.06.047. Epub 2011 Jul 19.

PMID:
21775131
10.

Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?

Zimmermann C, Seccareccia D, Booth CM, Cottrell W.

J Pain Palliat Care Pharmacother. 2005;19(2):25-31.

PMID:
16061458
11.

Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.

Lawlor PG, Turner KS, Hanson J, Bruera ED.

Cancer. 1998 Mar 15;82(6):1167-73.

PMID:
9506365
12.

Intermittent subcutaneous methadone administration in the management of cancer pain.

Centeno C, Vara F.

J Pain Palliat Care Pharmacother. 2005;19(2):7-12.

PMID:
16061456
13.

[Methadone in the treatment of chronic non-malignant pain].

Bendiksen A, McGehee E, Handberg G.

Ugeskr Laeger. 2007 Apr 23;169(17):1568-72. Danish.

PMID:
17484827
14.

Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain.

Moksnes K, Kaasa S, Paulsen Ø, Rosland JH, Spigset O, Dale O.

Eur J Clin Pharmacol. 2012 Aug;68(8):1147-56. doi: 10.1007/s00228-012-1228-3. Epub 2012 Feb 29.

PMID:
22374345
15.

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.

Bruera E, Pereira J, Watanabe S, Belzile M, Kuehn N, Hanson J.

Cancer. 1996 Aug 15;78(4):852-7.

16.

Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.

Mercadante S, Sapio M, Serretta R, Caligara M.

Ann Oncol. 1996 Aug;7(6):613-7.

17.

Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.

Benítez-Rosario MA, Salinas-Martín A, Aguirre-Jaime A, Pérez-Méndez L, Feria M.

J Pain Symptom Manage. 2009 Jun;37(6):1061-8. doi: 10.1016/j.jpainsymman.2008.05.016. Epub 2009 Jan 25.

PMID:
19171458
18.

Methadone for cancer pain: what have we learned from clinical studies?

Soares LG.

Am J Hosp Palliat Care. 2005 May-Jun;22(3):223-7. Review.

PMID:
15909785
19.

Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain.

Moryl N, Santiago-Palma J, Kornick C, Derby S, Fischberg D, Payne R, Manfredi PL.

Pain. 2002 Apr;96(3):325-8.

PMID:
11973005
20.

Methadone in the treatment of pain and terminal delirum in advanced cancer patients.

Moryl N, Kogan M, Comfort C, Obbens E.

Palliat Support Care. 2005 Dec;3(4):311-7.

PMID:
17039986
Items per page

Supplemental Content

Write to the Help Desk